Efficacy and safety of ubrogepant for migraine: a meta-analysis of randomized controlled studies.

Wu, Shu-Zhi; Chen, Linglong

Wu, Shu-Zhi; Chen, Linglong.

Afiliação

Wu SZ; Neurology Department, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Third Affiliated Hospital of Shanghai University, Wenzhou People's Hospital, Wenzhou, Zhejiang, China.
Chen L; Emergency Medicine Department, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Third Affiliated Hospital of Shanghai University, Wenzhou People's Hospital, Wenzhou, Zhejiang, China.

Int J Neurosci ; : 1-7, 2022 Oct 26.

Article em En | MEDLINE | ID: mdl-35999672

Palavras-chave

Migraine; randomized controlled trial; treatment outcome; ubrogepant

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Int J Neurosci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google